Epinephrine
Epinephrine is a fast-acting emergency medicine used to treat severe allergic reactions (anaphylaxis) and, in certain injectable forms, low blood pressure from septic shock.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 88 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Epinephrine: Patient Information Guide
A plain-language walkthrough of Epinephrine — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Epinephrine is used across several products and delivery forms to treat life-threatening allergic emergencies and, in specific injectable preparations, low blood pressure from septic shock.
- Emergency treatment of anaphylaxis (severe allergic reactions) triggered by insect stings or bites, foods, drugs, diagnostic substances, allergen immunotherapy, or unknown/exercise-related causes — supported across epinephrine auto-injectors, Adrenalin injection, and Neffy nasal spray
- Neffy nasal spray is approved specifically for adults and children 4 years and older who weigh at least 15 kg
- Adrenalin injection (intramuscular, subcutaneous, or intravenous) is indicated to raise blood pressure in adult patients with low blood pressure caused by septic shock
- Adrenalin (epinephrine in sodium chloride) intravenous infusion is indicated for low blood pressure from septic shock in adults
- Primatene Mist inhaler is used for temporary relief of mild intermittent asthma symptoms — wheezing, chest tightness, and shortness of breath
⚙️How it works▾
Epinephrine activates two families of receptors throughout the body — alpha and beta adrenergic receptors. Stimulating alpha receptors constricts (tightens) blood vessels, reversing the dangerous blood pressure drop and fluid leakage that occur during anaphylaxis. Stimulating beta receptors relaxes the muscles around the airways, rapidly opening them to relieve wheezing and breathlessness. Together, these actions also reduce hives, itching, swelling (including angioedema — swelling under the skin), and gastrointestinal symptoms tied to the allergic reaction.
💊How it's taken▾
The right form and amount of epinephrine depend on the situation, the patient's weight, and the specific product prescribed. Auto-injectors and vial-based injections go into the outer thigh (intramuscularly or subcutaneously); Neffy goes into a nostril; Primatene Mist is inhaled; and intravenous Adrenalin is given only in clinical settings. Injections may be repeated every 5–10 minutes if needed, but more than two doses should only be given under direct medical supervision.
- Always follow your prescriber's instructions and the directions printed on your specific device or package
- After using any epinephrine product for anaphylaxis, go to an emergency room immediately — even if you feel better
- Keep two doses available at all times if prescribed a portable product
🤒Side effects — in detail▾
Common side effects of epinephrine reflect its powerful action on the heart and nervous system, and — for nasal spray — local irritation in the nose.
- Nasal discomfort, runny nose, sneezing, or nasal congestion (Neffy)
- Headache
- Feeling jittery or anxious
- Rapid heartbeat (tachycardia)
- Nausea or vomiting
- Dizziness
- Throat irritation
- Sweating, paleness, or tremor
More serious reactions — including dangerous heart rhythm problems (arrhythmias), very high blood pressure, cerebral hemorrhage (bleeding in the brain), and serious skin infections at the injection site — have been reported. Seek emergency care if you experience chest pain, irregular heartbeat, severe headache, or any signs of infection at an injection site.
⚠️Warnings & precautions▾
- Always go to the ER after use: Epinephrine is emergency supportive therapy — it is not a substitute for hospital care. Call 911 or have someone take you to the nearest emergency room after every use.
- Inject only into the outer thigh: Never inject into the buttocks (risk of serious bacterial infection including gas gangrene), and never into fingers, hands, or feet (risk of dangerously reduced blood flow to those areas).
- Serious skin infections: Rare but life-threatening infections (including necrotizing fasciitis — rapidly spreading tissue infection) have occurred at injection sites. Watch for persistent redness, warmth, swelling, or tenderness and seek care promptly.
- Heart disease: Epinephrine should be used with caution in people with heart disease, arrhythmias, coronary artery disease, or high blood pressure — but it must never be withheld in a true life-threatening emergency.
- Children: Hold a young child's leg firmly before and during injection to prevent injury from kicking or movement.
- Sulfite sensitivity: Some epinephrine products contain sodium metabisulfite. This should not prevent use in a life-threatening situation — the risk of untreated anaphylaxis is far greater.
🔀What it interacts with▾
Several medications can make epinephrine stronger, weaker, or more likely to cause heart problems — always tell your doctor and pharmacist everything you take.
- Tricyclic antidepressants and MAO inhibitors: Can strongly amplify epinephrine's effects, raising the risk of dangerously high blood pressure and heart problems
- Cardiac glycosides, diuretics, anti-arrhythmics: Increase the risk of abnormal heart rhythms when used alongside epinephrine
- Beta-blockers (e.g., propranolol): Can blunt epinephrine's ability to open airways and stimulate the heart — potentially reducing its effectiveness
- Alpha-blockers (e.g., phentolamine): Can block epinephrine's blood-pressure-raising effects
- Levothyroxine and certain antihistamines (e.g., diphenhydramine, chlorpheniramine): May intensify epinephrine's effects
- COMT inhibitors (e.g., entacapone): Can potentiate (strengthen) epinephrine's actions
- Ergot alkaloids: May reverse epinephrine's blood pressure effects
- Neffy and other nasal products: Neffy may change the nasal lining for up to 2 weeks after use, potentially increasing absorption of other nasal spray medications
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Tell your doctor if you have heart disease, coronary artery disease, irregular heart rhythm, or high blood pressure
- Tell your doctor if you have hyperthyroidism (overactive thyroid), diabetes, or Parkinson's disease
- Older adults are more sensitive to epinephrine and at higher risk for serious side effects — use with caution
- Pregnant women: do not delay treatment for anaphylaxis — untreated anaphylaxis is dangerous for both mother and baby; decades of evidence have not shown a clear drug-related risk of birth defects at therapeutic doses
- Breastfeeding: epinephrine transfers into breast milk in very low amounts; do not delay emergency treatment
- Neffy is not approved for children under 4 years old or those weighing less than 15 kg
- There are no absolute contraindications to epinephrine in a life-threatening allergic emergency — its benefits outweigh the risks in anaphylaxis regardless of underlying conditions
🚑If you take too much▾
Too much epinephrine can cause extremely high blood pressure, which may lead to bleeding in the brain (cerebrovascular hemorrhage) — particularly in older adults. Overdose can also cause a buildup of fluid in the lungs, dangerous heart rhythm problems (including fatal ventricular fibrillation), very pale and cold skin, and kidney failure.
If you suspect an overdose, call Poison Control at 1-800-222-1222 or seek emergency medical care immediately. Treatment is primarily supportive and focuses on managing blood pressure and heart rhythm.
📡Pharmacodynamics — effects in the body▾
Epinephrine raises both systolic blood pressure and pulse rate, which helps reverse the cardiovascular collapse of anaphylaxis. Studies of Neffy nasal spray showed that blood pressure and heart rate responses after one nasal dose were generally within the range seen after intramuscular epinephrine injection during the first 10 minutes. Nasal congestion (such as from allergic rhinitis) may affect how quickly Neffy is absorbed, and the full clinical meaning of blood pressure and pulse changes observed in healthy volunteers may differ from responses in someone actively experiencing anaphylaxis.
🔬Pharmacokinetics — how your body processes it▾
After a single nasal dose of Neffy, plasma epinephrine concentrations over 60 minutes were generally within the range seen after an intramuscular injection. Neffy's peak concentration (Cmax) was reached at a median of about 30 minutes in healthy adults — somewhat later than with an auto-injector but in a clinically similar range. Nasal congestion from allergic rhinitis can initially speed absorption but may reduce overall exposure after about 20 minutes. Epinephrine is rapidly broken down by the body, which is why its effects are short-lived and repeat dosing may be needed.
📦How to store it▾
Protect from light. Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) . Do not refrigerate.
📄 Written from Epinephrine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Epinephrine — the kind of thing our pharmacy team would talk through with you at the counter.
Why do I need to go to the ER after using my EpiPen or Auvi-Q if I already feel better? ▾
Where exactly do I inject it, and does it matter? ▾
How does Neffy (the nasal spray) work differently from an injection? ▾
I take a beta-blocker for my heart. Will epinephrine still work for me? ▾
Is it safe to use epinephrine if I'm pregnant? ▾
What side effects should I expect after using epinephrine, and which ones mean I should call for help? ▾
Is Epinephrine available over the counter? ▾
When was Epinephrine first available? ▾
Who makes Epinephrine? ▾
💬 Answers drafted from Epinephrine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Epinephrine comes
Epinephrine is available in 6 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Injection
How this form is used
- Epinephrine injection auto-injectors (including Auvi-Q, EpiPen, and epinephrine USP auto-injectors) are used for emergency treatment of anaphylaxis in people at increased risk of severe allergic reactions
- Adrenalin injection is used for emergency treatment of anaphylaxis and to raise blood pressure in adult patients with low blood pressure from septic shock
- Adrenalin (epinephrine in sodium chloride) intravenous infusion is indicated to raise blood pressure in adults with septic shock
- Auvi-Q is available in three dose strengths selected by body weight for emergency anaphylaxis treatment
- Auto-injectors (Auvi-Q, EpiPen, and epinephrine USP auto-injectors) should be injected into the outer thigh — through clothing if needed — never into the buttocks, fingers, hands, or feet
- Adrenalin vial injection should be given into the anterolateral (outer) thigh; the injection may be repeated every 5 to 10 minutes if needed — do not inject repeatedly at the same spot
- Adrenalin (epinephrine in sodium chloride) for intravenous use requires no further dilution and must be infused into a large vein; weaning gradually is recommended
- After any injection, go to the nearest emergency room immediately for further monitoring and care
Show 8 more strengths Show fewer strengths
Nasal spray
How this form is used
- Neffy is approved for emergency treatment of Type I allergic reactions, including anaphylaxis, in adults and children 4 years and older who weigh at least 15 kg (about 33 lbs)
- Neffy provides a needle-free option for epinephrine delivery during an anaphylactic emergency
- Neffy is sprayed into one nostril; dose is based on the patient's body weight
- If symptoms do not improve or worsen after the first dose, a second spray into the same nostril can be given at least 5 minutes later using a new nasal spray
- It is recommended to have two Neffy nasal sprays available at all times
- After using Neffy, seek emergency medical care immediately
Inhaler
How this form is used
- Primatene Mist is used for temporary relief of mild symptoms of intermittent asthma
- Primatene Mist relieves wheezing, chest tightness, and shortness of breath
- Primatene Mist is inhaled through the mouth via aerosol
- Follow the dosing directions on the Primatene Mist package carefully
Other oral form
Oral solution
Topical solution
📊 Epinephrine across the U.S. market
How Epinephrine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (30) · Kit (8) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Epinephrine is used
A general measure of how commonly Epinephrine is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Epinephrine is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Epinephrine prescribed? Of the 1,596 medications we measure, Epinephrine ranks #158 by Medicaid prescriptions — more than 90% of them.
Utilization by Epinephrine product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector Most dispensed
Summed across the 3 of 15 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1870207
NDA020800 0.3 ML epinephrine 1 MG/ML Auto-Injector
Summed across the 1 of 14 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1870230
NDA019430 0.3 ML epinephrine 0.5 MG/ML Auto-Injector
Summed across the 3 of 11 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 727316
NDA020800 0.15 ML epinephrine 1 MG/ML Auto-Injector
Summed across the 1 of 7 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1870225
NDA201739 0.3 ML epinephrine 1 MG/ML Auto-Injector
Summed across the 1 of 7 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1870205
1 ML epinephrine 1 MG/ML Injection
Summed across the 3 of 55 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1660014
epinephrine 20 MG/ML Nasal Spray
Summed across the 1 of 3 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2693442
NDA201739 0.15 ML epinephrine 1 MG/ML Auto-Injector
Summed across the 1 of 7 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1870232
NDA201739 0.1 ML epinephrine 1 MG/ML Auto-Injector
Summed across the 1 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1991328
epinephrine 1 MG/ML Injectable Solution
Summed across the 5 of 30 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 310132
10 ML epinephrine 0.1 MG/ML Prefilled Syringe
Summed across the 1 of 21 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 727373
epinephrine 10 MG/ML Nasal Spray
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2709207
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Epinephrine, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 22 of 177 listed Epinephrine NDCs with Medicaid activity.
🔍 Compare Epinephrine products
A representative set of FDA-listed product records for Epinephrine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Inhaler | ||||
| 125 mcg | Respiratory (inhalation) | Armstrong Pharmaceuticals, Inc. × 4 listings | NDA | View NDC → |
| 💊Injection | ||||
| 0.1 mg/mL | Intravenous | A-S Medication Solutions × 2 listings | NDA | View NDC → |
| 0.1 mg/mL | Intracardiac; Intravenous | A-S Medication Solutions | UNAPPROVED DRUG OTHER | View NDC → |
| 0.1 mg/mL | Endotracheal; Intracardiac; Intravenous | A-S Medication Solutions | UNAPPROVED DRUG OTHER | Find on DailyMed ↗ |
| 0.15 mg/0.3 mL | Intramuscular, Subcutaneous | A-S Medication Solutions | ANDA | View NDC → |
| 0.15 mg/0.3 mL | Intramuscular; Subcutaneous | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| 0.3 mg/0.3 mL | Intramuscular | A-S Medication Solutions × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 0.3 mg/0.3 mL | Subcutaneous | A-S Medication Solutions × 3 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 0.3 mg/0.3 mL | Intramuscular; Subcutaneous | A-S Medication Solutions | ANDA | Find on DailyMed ↗ |
| 1 mg/mL | Intramuscular, Intraocular, Intravenous, Subcutaneous | A-S Medication Solutions × 2 listings | NDA | View NDC → |
| 1 mg/mL | Intravenous | A-S Medication Solutions × 2 listings | NDA | View NDC → |
| 0.3 mg/0.3 mL | Subcutaneous | Advanced Rx Pharmacy of Tennessee, LLC × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 1 mg/mL | Intramuscular, Intravenous, Subcutaneous | American Regent, Inc. | ANDA | View NDC → |
| 1 mg/mL | Intramuscular, Subcutaneous | American Regent, Inc. | ANDA | View NDC → |
| 1 mg/mL | Intramuscular; Subcutaneous | American Regent, Inc. | ANDA | View NDC → |
| 1 mg/mL | Intramuscular, Intravenous, Subcutaneous | Amneal Pharmaceuticals LLC | ANDA | View NDC → |
| 0.15 mg/0.15 mL | Subcutaneous | Amneal Pharmaceuticals of New York LLC × 3 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 0.3 mg/0.3 mL | Subcutaneous | Amneal Pharmaceuticals of New York LLC × 3 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 1 mg/mL | Intramuscular, Intravenous, Subcutaneous | Amneal Pharmaceuticals Private Limited | ANDA | View NDC → |
| 0.15 mg/0.15 mL | Subcutaneous | Asclemed USA, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 0.3 mg/0.3 mL | Intramuscular | Asclemed USA, Inc. | NDA | View NDC → |
| 0.3 mg/0.3 mL | Subcutaneous | Asclemed USA, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 0.3 mg/0.3 mL | Intramuscular, Subcutaneous | Asclemed USA, Inc. | ANDA | View NDC → |
| 0.3 mg/0.3 mL | Subcutaneous | Asclemed Usa Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 0.3 mg/0.3 mL | Subcutaneous | AvKARE | NDA AUTHORIZED GENERIC | View NDC → |
| 16 mcg/mL | Intravenous | Baxter Healthcare Corporation × 2 listings | NDA | View NDC → |
| 64 mcg/mL | Intravenous | Baxter Healthcare Corporation × 2 listings | NDA | View NDC → |
| 1 mg/mL | Intramuscular; Intravenous; Subcutaneous | Belcher Pharmaceuticals, LLC | NDA | View NDC → |
| 1 mg/mL | Intramuscular, Intravenous, Subcutaneous | BPI Labs, LLC × 3 listings | NDA | View NDC → |
| 1 mg/mL | Intravenous | BPI Labs, LLC × 2 listings | NDA | View NDC → |
| 1 mg/mL | Intramuscular; Intravenous; Subcutaneous | BPI Labs, LLC × 3 listings | NDA | View NDC → |
| 30 mg/30 mL | Intramuscular, Intravenous, Subcutaneous | BPI Labs, LLC | NDA | View NDC → |
| 0.1 mg/mL | Intracardiac; Intravenous | Bpi Labs Llc | UNAPPROVED DRUG OTHER | View NDC → |
| 0.15 mg/0.3 mL | Intramuscular, Subcutaneous | Bryant Ranch Prepack | ANDA | View NDC → |
| 0.15 mg/0.3 mL | Intramuscular; Subcutaneous | Bryant Ranch Prepack | ANDA | View NDC → |
| 0.5 mg/mL | — | Catalent Indiana, LLC | DRUG FOR FURTHER PROCESSING | View NDC → |
| 1 mg/mL | — | Catalent Indiana, LLC | DRUG FOR FURTHER PROCESSING | View NDC → |
| 0.1 mg/mL | Endotracheal; Intracardiac; Intravenous | General Injectables & Vaccines, Inc | UNAPPROVED DRUG OTHER | Find on DailyMed ↗ |
| 1 mg/mL | Intramuscular, Intravenous, Subcutaneous | Gland Pharma Limited × 2 listings | ANDA | View NDC → |
| 1 mg/mL | Intramuscular, Intravenous, Subcutaneous | Glenmark Pharmaceuticals Inc., Usa × 2 listings | ANDA | View NDC → |
| 0.1 mg/mL | Intravenous | Henry Schein, Inc. | NDA | View NDC → |
| 0.1 mg/mL | Endotracheal; Intracardiac; Intravenous | Henry Schein, Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 0.1 mg/0.1 mL | Intramuscular | HF Acquisition Co LLC, DBA HealthFirst × 2 listings | NDA | View NDC → |
| 0.1 mg/mL | Intravenous | HF Acquisition Co LLC, DBA HealthFirst × 4 listings | NDA | View NDC → |
| 0.1 mg/mL | Intracardiac; Intravenous | HF Acquisition Co LLC, DBA HealthFirst × 2 listings | UNAPPROVED DRUG OTHER | View NDC → |
| 0.1 mg/mL | Endotracheal; Intracardiac; Intravenous | HF Acquisition Co LLC, DBA HealthFirst | UNAPPROVED DRUG OTHER | View NDC → |
| 0.15 mg/0.3 mL | Intramuscular | HF Acquisition Co LLC, DBA HealthFirst × 2 listings | NDA | View NDC → |
| 0.15 mg/0.15 mL | Subcutaneous | HF Acquisition Co LLC, DBA HealthFirst × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 0.15 mg/0.15 mL | Intramuscular | HF Acquisition Co LLC, DBA HealthFirst × 3 listings | NDA | View NDC → |
| 0.3 mg/0.3 mL | Subcutaneous | HF Acquisition Co LLC, DBA HealthFirst × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 0.3 mg/0.3 mL | Intramuscular | HF Acquisition Co LLC, DBA HealthFirst × 5 listings | NDA | View NDC → |
| 1 mg/mL | Intramuscular, Intravenous, Subcutaneous | HF Acquisition Co LLC, DBA HealthFirst × 2 listings | NDA | View NDC → |
| 1 mg/mL | Intramuscular, Intravenous, Subcutaneous | HF Acquisition Co LLC, DBA HealthFirst × 2 listings | ANDA | View NDC → |
| 1 mg/mL | Intramuscular, Intravenous, Subcutaneous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 0.1 mg/mL | Intravenous | Hospira, Inc. × 2 listings | NDA | View NDC → |
| 1 mg/mL | — | Hospira, Inc. | DRUG FOR FURTHER PROCESSING | View NDC → |
| 0.1 mg/mL | Intravenous | International Medication Systems, Limited × 2 listings | NDA | View NDC → |
| 0.1 mg/mL | Intracardiac; Intravenous | International Medication Systems, Limited | UNAPPROVED DRUG OTHER | View NDC → |
| 1 mg/mL | Intramuscular, Intravenous, Subcutaneous | International Medication Systems, Limited | ANDA | View NDC → |
| 1 mg/mL | Intramuscular; Intravenous; Subcutaneous | International Medication Systems, Limited | ANDA | View NDC → |
| 0.1 mg/0.1 mL | Intramuscular | kaleo, Inc × 3 listings | NDA | View NDC → |
| 0.15 mg/0.15 mL | Intramuscular | kaleo, Inc × 3 listings | NDA | View NDC → |
| 0.3 mg/0.3 mL | Intramuscular | kaleo, Inc × 3 listings | NDA | View NDC → |
| 0.1 mg/mL | Intravenous | Medical Purchasing Solutions, LLC × 3 listings | NDA | View NDC → |
| 0.1 mg/mL | Intracardiac; Intravenous | Medical Purchasing Solutions, LLC × 2 listings | UNAPPROVED DRUG OTHER | View NDC → |
| 0.1 mg/mL | Endotracheal; Intracardiac; Intravenous | Medical Purchasing Solutions, LLC | UNAPPROVED DRUG OTHER | View NDC → |
| 0.15 mg/0.3 mL | Intramuscular | Medical Purchasing Solutions, LLC × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 0.15 mg/0.15 mL | Subcutaneous | Medical Purchasing Solutions, LLC | NDA AUTHORIZED GENERIC | Find on DailyMed ↗ |
| 0.15 mg/0.15 mL | Intramuscular | Medical Purchasing Solutions, LLC × 3 listings | NDA | View NDC → |
| 0.3 mg/0.3 mL | Intramuscular | Medical Purchasing Solutions, LLC × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 0.3 mg/0.3 mL | Subcutaneous | Medical Purchasing Solutions, LLC | NDA AUTHORIZED GENERIC | Find on DailyMed ↗ |
| 0.3 mg/0.3 mL | Intramuscular | Medical Purchasing Solutions, LLC × 3 listings | NDA | View NDC → |
| 1 mg/mL | Intramuscular, Intravenous, Subcutaneous | Medical Purchasing Solutions, LLC | NDA | View NDC → |
| 1 mg/mL | Intramuscular; Intravenous; Subcutaneous | Medical Purchasing Solutions, LLC | NDA | View NDC → |
| 1 mg/mL | Intramuscular, Intravenous, Subcutaneous | Medical Purchasing Solutions, LLC. | NDA | View NDC → |
| 0.15 mg/0.3 mL | Intramuscular | Mylan Specialty L.P. × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 0.15 mg/0.3 mL | Intramuscular | Mylan Specialty L.P. × 2 listings | NDA | View NDC → |
| 0.3 mg/0.3 mL | Intramuscular | Mylan Specialty L.P. × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 0.3 mg/0.3 mL | Intramuscular | Mylan Specialty L.P. × 2 listings | NDA | View NDC → |
| 1 mg/mL | — | Novocol Pharmaceutical of Canada, Inc. | EXPORT ONLY | View NDC → |
| 1 mg/mL | — | Novo Nordisk Production Belgium SA | DRUG FOR FURTHER PROCESSING | View NDC → |
| 8 mcg/mL | Intravenous | Par Health USA, LLC | NDA | View NDC → |
| 16 mcg/mL | Intravenous | Par Health USA, LLC | NDA | View NDC → |
| 20 mcg/mL | Intravenous | Par Health USA, LLC | NDA | View NDC → |
| 32 mcg/mL | Intravenous | Par Health USA, LLC | NDA | View NDC → |
| 40 mcg/mL | Intravenous | Par Health USA, LLC | NDA | View NDC → |
| 1 mg/mL | Intramuscular, Intravenous, Subcutaneous | Par Health USA, LLC × 6 listings | NDA | View NDC → |
| 1 mg/mL | Intramuscular; Intravenous; Subcutaneous | Par Pharmaceutical, Inc. × 8 listings | NDA | View NDC → |
| 0.1 mg/mL | Intravenous | ProPharma Distribution | NDA | View NDC → |
| 1 mg/mL | Intramuscular, Intravenous, Subcutaneous | ProPharma Distribution | NDA | View NDC → |
| 0.3 mg/0.3 mL | Intramuscular, Subcutaneous | Redpharm Drug | ANDA | View NDC → |
| 0.1 mg/mL | Intravenous | Remedyrepack Inc. × 2 listings | NDA | View NDC → |
| 0.1 mg/mL | Intracardiac; Intravenous | Remedyrepack Inc. × 2 listings | UNAPPROVED DRUG OTHER | View NDC → |
| 0.15 mg/0.3 mL | Intramuscular; Subcutaneous | Remedyrepack Inc. × 2 listings | ANDA | View NDC → |
| 0.15 mg/0.3 mL | Intramuscular | Remedyrepack Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 0.15 mg/0.15 mL | Subcutaneous | Remedyrepack Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 0.3 mg/0.3 mL | Subcutaneous | Remedyrepack Inc. × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 0.3 mg/0.3 mL | Intramuscular, Subcutaneous | Remedyrepack Inc. | ANDA | View NDC → |
| 0.3 mg/0.3 mL | Intramuscular | Remedyrepack Inc. × 2 listings | NDA | View NDC → |
| 0.3 mg/0.3 mL | Intramuscular; Subcutaneous | Remedyrepack Inc. × 2 listings | ANDA | View NDC → |
| 1 mg/mL | Intramuscular, Intravenous, Subcutaneous | Remedyrepack Inc. × 3 listings | NDA | View NDC → |
| 1 mg/mL | Intramuscular; Intravenous; Subcutaneous | Remedyrepack Inc. | NDA | View NDC → |
| 0.15 mg/0.3 mL | Intramuscular | Sina Health Inc | NDA AUTHORIZED GENERIC | View NDC → |
| 0.15 mg/0.15 mL | Subcutaneous | Sina Health Inc | NDA AUTHORIZED GENERIC | View NDC → |
| 0.3 mg/0.3 mL | Subcutaneous | Sina Health Inc | NDA AUTHORIZED GENERIC | View NDC → |
| 0.3 mg/0.3 mL | Intramuscular | Sina Health Inc | NDA AUTHORIZED GENERIC | View NDC → |
| 1 mg/mL | Intramuscular, Intravenous, Subcutaneous | Sina Health Inc | NDA | View NDC → |
| 0.3 mg/0.3 mL | Intramuscular, Subcutaneous | Sportpharm LLC | ANDA | View NDC → |
| 0.3 mg/0.3 mL | Subcutaneous | Sportpharm LLC | NDA AUTHORIZED GENERIC | View NDC → |
| 0.15 mg/0.3 mL | Intramuscular, Subcutaneous | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 0.3 mg/0.3 mL | Intramuscular, Subcutaneous | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 0.5 mg/mL | — | Teva Pharmaceuticals USA, Inc. | DRUG FOR FURTHER PROCESSING | View NDC → |
| 1 mg/mL | — | Teva Pharmaceuticals USA, Inc. | DRUG FOR FURTHER PROCESSING | View NDC → |
| 0.15 mg/0.3 mL | Intramuscular; Subcutaneous | Uswm, Llc | NDA | View NDC → |
| 0.3 mg/0.3 mL | Intramuscular; Subcutaneous | Uswm, Llc | NDA | View NDC → |
| 0.15 mg/0.3 mL | Intramuscular | Viatris Specialty LLC | NDA AUTHORIZED GENERIC | View NDC → |
| 0.15 mg/0.3 mL | Intramuscular | Viatris Specialty LLC | NDA | View NDC → |
| 0.3 mg/0.3 mL | Intramuscular | Viatris Specialty LLC | NDA AUTHORIZED GENERIC | View NDC → |
| 0.3 mg/0.3 mL | Intramuscular | Viatris Specialty LLC | NDA | View NDC → |
Showing 200 of 275 products — FDA National Drug Code Directory. See every product, package size and price: browse all 275 Epinephrine NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Epinephrine — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Epinephrine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Epinephrine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 3992 10 dose forms · 32 strengths
-
Dose form (SCDF) Auto-Injector RxCUI 1661387In current FDA listingsClinical drug / strength (SCD) NDA019430 0.3 ML epinephrine 0.5 MG/MLRxCUI 727316NDA019430 0.3 ML epinephrine 1 MG/MLRxCUI 1870207NDA020800 0.15 ML epinephrine 1 MG/MLRxCUI 1870225NDA020800 0.3 ML epinephrine 1 MG/MLRxCUI 1870230NDA201739 0.1 ML epinephrine 1 MG/MLRxCUI 1991328NDA201739 0.15 ML epinephrine 1 MG/MLRxCUI 1870232NDA201739 0.3 ML epinephrine 1 MG/MLRxCUI 1870205 -
Dose form (SCDF) Inhalation Powder RxCUI 2108366No current FDA listingClinical drug / strength (SCD) 0.22 MGRxCUI 1546217 -
Dose form (SCDF) Inhalation Solution RxCUI 2108382No current FDA listing -
Dose form (SCDF) Injectable Solution RxCUI 372030In current FDA listings -
Dose form (SCDF) Injection RxCUI 1660013In current FDA listingsClinical drug / strength (SCD) 1 ML epinephrine 1 MG/MLRxCUI 1660014250 ML epinephrine 0.008 MG/MLRxCUI 2719206250 ML epinephrine 0.016 MG/MLRxCUI 2695029250 ML epinephrine 0.02 MG/MLRxCUI 2713737250 ML epinephrine 0.032 MG/MLRxCUI 2707356250 ML epinephrine 0.04 MG/MLRxCUI 2719203250 ML epinephrine 0.064 MG/MLRxCUI 2707568 -
Dose form (SCDF) Metered Dose Inhaler RxCUI 746206In current FDA listingsClinical drug / strength (SCD) 160 ACTUAT epinephrine 0.125 MG/ACTUATRxCUI 2109083270 ACTUAT epinephrine 0.22 MG/ACTUATRxCUI 883806 -
Dose form (SCDF) Nasal Solution RxCUI 372031In current FDA listingsClinical drug / strength (SCD) 1 MG/MLRxCUI 313967 -
Dose form (SCDF) Nasal Spray RxCUI 2693441In current FDA listings -
Dose form (SCDF) Ophthalmic Solution RxCUI 372029No current FDA listingClinical drug / strength (SCD) 0.5 MG/MLRxCUI 1067791 MG/MLRxCUI 2442842.5 MG/MLRxCUI 3101275 MG/MLRxCUI 10678010 MG/MLRxCUI 141848 -
Dose form (SCDF) Prefilled Syringe RxCUI 727310No current FDA listingClinical drug / strength (SCD) 0.3 ML epinephrine 0.5 MG/MLRxCUI 21787900.3 ML epinephrine 1 MG/MLRxCUI 19891121 ML epinephrine 1 MG/MLRxCUI 263753310 ML epinephrine 0.1 MG/MLRxCUI 727373
Look up RxCUI 3992 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Epinephrine is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
RxNorm drug class
Epinephrine belongs to the alpha-Adrenergic Agonist class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 88 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Mylan Specialty L.P. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.